Loading organizations...
§ Private Profile · Barcelona, Catalonia, Spain
Medical device company developing minimally invasive endovascular devices for vascular surgeons, focused on aortic dissection and tissue regeneration.
Based in Barcelona, Spain, Aortyx is a medical device company that develops minimally invasive endovascular solutions, including a catheter-deployed bioresorbable patch to treat aortic dissection. The pre-commercial startup focuses on tissue engineering technologies that mimic arterial properties to promote vascular regeneration and address the limitations of traditional open surgery or stents. Operating with a team of nearly 20 employees, the company has secured approximately €16.8 million in total equity funding alongside €5 million in public grants and soft loans. The firm recently raised a €13.8 million Series A round to fund upcoming first-in-human clinical trials, backed by notable investors including Clave Capital, Nina Capital, and the EIC Fund. Aortyx was founded in 2018 by Jordi Martorell, Noemí Balà, Salvador Borrós, and Vicenç Riambau as a spin-off from IQS and Hospital Clínic de Barcelona.
Aortyx has raised $16.8M across 2 funding rounds.
Aortyx has raised $16.8M in total across 2 funding rounds.
Aortyx has raised $16.8M in total across 2 funding rounds.
Aortyx's investors include Jordi Ferrer Rendé, CDTI Innvierte, Sergio San Agustín, European Innovation Council, Nara Capital, Genesis Ventures.
Aortyx has raised $16.8M across 2 funding rounds. Most recently, it raised $16.0M Series A in June 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 12, 2025 | $16M Series A | Jordi Ferrer Rendé | CDTI Innvierte, Sergio SAN Agustín, European Innovation Council, Nara Capital | Announced |
| Mar 6, 2020 | $730K Venture Round | Genesis Ventures | — | Announced |